Kura Oncology Ownership | Who Owns Kura Oncology?

Overview Forecast RevenueFinancials Chart Transcripts

Kura Oncology Ownership Summary

Kura Oncology is owned by 94.66% institutional investors, 1.05% insiders, and 4.29% retail investors. Suvretta capital management is the largest institutional shareholder, holding 8.43% of KURA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.54% of its assets in Kura Oncology shares.

KURA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Kura Oncology	94.66%	1.05%	4.29%
Sector	Healthcare Stocks	88.01%	8.90%	3.09%
Industry	Biotech Stocks	109.70%	8.77%	-18.47%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Suvretta capital management	7.07M	8.43%	$145.56M
Blackrock	6.97M	8.30%	$143.43M
Deerfield management company, l.p. (series c)	5.41M	6.45%	$111.42M
Paradigm biocapital advisors lp	4.54M	5.41%	$93.47M
Bvf inc/il	4.08M	4.87%	$84.05M
Vanguard group	4.04M	4.82%	$83.19M
Avoro capital advisors	3.54M	4.22%	$72.92M
State street	2.88M	3.44%	$59.39M
Holocene advisors, lp	2.69M	3.21%	$55.38M
Armistice capital	2.35M	2.80%	$48.39M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Foresite capital management iv	1.85M	25.59%	$38.09M
Suvretta capital management	7.07M	5.35%	$145.56M
Alethea capital management	265.91K	4.15%	$5.48M
Prosight management, lp	629.90K	3.88%	$12.97M
Ally bridge group (ny)	306.76K	3.76%	$6.32M
Paradigm biocapital advisors lp	4.54M	3.58%	$93.47M
Tcg crossover management	1.42M	3.06%	$29.31M
Acuta capital partners	163.00K	2.83%	$3.36M
Exome asset management	131.74K	2.42%	$2.71M
Bvf inc/il	4.08M	2.36%	$84.05M

Top Buyers

Holder	Shares	% Assets	Change
Paradigm biocapital advisors lp	4.54M	3.58%	1.40M
Deep track capital, lp	384.76K	0.24%	384.76K
Sofinnova investments	825.24K	0.88%	323.30K
Armistice capital	2.35M	0.61%	302.00K
Candriam s.c.a.	906.48K	0.11%	255.06K

Top Sellers

Holder	Shares	% Assets	Change
State street	2.88M	0.00%	-1.32M
Bvf inc/il	4.08M	2.36%	-704.26K
Ecor1 capital	-	-	-700.00K
Dimensional fund advisors lp	894.62K	0.00%	-468.82K
Prosight management, lp	629.90K	3.88%	-330.10K

New Positions

Holder	Shares	% Assets	Change	Value
Deep track capital, lp	384.76K	0.24%	384.76K	$7.92M
Ameriprise financial	182.56K	0.00%	182.56K	$3.76M
Woodline partners lp	143.21K	0.03%	143.21K	$2.95M
Exome asset management	131.74K	2.42%	131.74K	$2.71M
Eversept partners, lp	72.32K	0.10%	72.32K	$1.49M

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-14.00
Quantbot technologies lp	-14.00
Massmutual trust co fsb/adv	-19.00
Main street group	-50.00
Innealta capital	-54.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	183	2.23%	82,304,529	2.31%	94	1.03%	82	-2.38%	56	-9.68%
Jun 30, 2024	179	4.68%	80,450,005	-0.33%	95	1.04%	84	-11.58%	62	31.91%
Mar 31, 2024	171	20.42%	80,714,791	2.51%	96	0.93%	95	33.80%	47	9.30%
Dec 31, 2023	142	5.97%	78,740,296	4.56%	101	1.07%	71	-4.05%	43	30.30%
Sep 30, 2023	134	-12.99%	75,309,454	0.24%	97	0.84%	74	-9.76%	33	-19.51%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	2.75M	3.54%	635.10K
iShares Russell 2000 ETF	1.96M	2.52%	-7.53K
SPDR® S&P Biotech ETF	1.66M	2.13%	-19.37K
Vanguard Institutional Extnd Mkt Idx Tr	1.22M	1.57%	31.25K
Fidelity Small Cap Index	742.92K	0.96%	4.11K
iShares Russell 2000 Growth ETF	667.91K	0.86%	-
Franklin Small Cap Growth Adv	621.52K	0.80%	-
Franklin US Small Cap Growth Equity	621.52K	0.80%	-57.60K
Franklin Biotechnology Discv A(acc)USD	533.90K	0.69%	-
HBM Healthcare Investments AG Ord	500.00K	0.65%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 28, 2025	DOYLE THOMAS JAMES	SVP, Finance & Accounting	Sell	$8.83K
Jan 28, 2025	DOYLE THOMAS JAMES	SVP, Finance & Accounting	Sell	$6.98K
Jan 28, 2025	DOYLE THOMAS JAMES	SVP, Finance & Accounting	Sell	$17.64K
Jan 28, 2025	DOYLE THOMAS JAMES	SVP, Finance & Accounting	Sell	$5.50K
Jan 28, 2025	Leoni Mollie	Chief Medical Officer	Sell	$17.74K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	1
2024 Q3	-	-
2024 Q2	-	1
2024 Q1	-	9
2023 Q4	-	-

KURA Ownership FAQ

Who Owns Kura Oncology?

Kura Oncology shareholders are primarily institutional investors at 94.66%, followed by 1.05% insiders and 4.29% retail investors. The average institutional ownership in Kura Oncology's industry, Biotech Stocks , is 109.70%, which Kura Oncology falls below.

Who owns the most shares of Kura Oncology?

Kura Oncology’s largest shareholders are Suvretta capital management (7.07M shares, 8.43%), Blackrock (6.97M shares, 8.30%), and Deerfield management company, l.p. (series c) (5.41M shares, 6.45%). Together, they hold 23.18% of Kura Oncology’s total shares outstanding.

Does Blackrock own Kura Oncology?

Yes, BlackRock owns 8.30% of Kura Oncology, totaling 6.97M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 143.43M$. In the last quarter, BlackRock increased its holdings by 66.44K shares, a 0.96% change.

Who is Kura Oncology’s biggest shareholder by percentage of total assets invested?

Foresite capital management iv is Kura Oncology’s biggest shareholder by percentage of total assets invested, with 25.59% of its assets in 1.85M Kura Oncology shares, valued at 38.09M$.

Who is the top mutual fund holder of Kura Oncology shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Kura Oncology shares, with 3.54% of its total shares outstanding invested in 2.75M Kura Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools